Ultime notizie per Rain Enhancement (NASDAQ:RAIN) Azioni

Rain Oncology

Rain Enhancement Technologies Holdco Inc operates to develop, manufacture, and commercialize ionization rainfall generation technology. This weather modification technology seeks to provide reliable access to water, and transform business, society, and the planet.

Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock

Rain Enhancement Technologies Holdco Inc

Rainicorn

Rain Enhancement Technologies Holdco, Inc. - Warrants

RAIN FOREST INTL INC by Rain Forest International, Inc.

Rain Forest International Inc

RAINBOW INTL CORP by Rainbow International Corp.

Rainbow International Corp

RAINBOW RARE EARTHS LTD by RAINBOW RARE EARTHS LTD.

Rainbow Rare Earths Ltd

RAINFOREST RESOURCES INC by Rainforest Resources Inc.

Rainforest Resources Inc

RAINIER PAC FINCL GRP INC by Rainier Pacific Financial Group, Inc.

Rainier Pacific Financial Group Inc

RAINMAKER SYSTEMS INC by Rainmaker Systems, Inc.

Rainmaker Systems Inc

RAINMAKER WORLDWIDE INC by Rainmaker Worldwide Inc.

Rainmaker Worldwide Inc

RAINY MOUNTAIN ROYLTY CRP by Rainy Mountain Royalty Corp

Rainy Mountain Royalty Corp

WIIM

FMST

Foremost Clean Energy shares are trading higher after the company announced it regained Nasdaq compliance.

European stock markets rallied Tuesday after officials in Brussels agreed to speed up tariff negotiations with Washington, a move that investors hope will head off a trans-Atlantic trade war and remove a major overhang for global risk assets.
The breakthrough followed U.S. President Donald Trump's weekend decision to postpone a threatened 50% levy on all European Union imports until 9 July. With the immediate tariff deadline pushed back, U.S. equities opened sharply higher. The Dow Jones Industrial Average added about 600 points, while the tech-heavy Nasdaq Composite rose more than 2%.&nbsp;
Euro-area blue-chips tracked the move, and pan-European exchange-traded funds (ETFs) saw some of their heaviest buying in weeks.
Don't Miss:&nbsp;
<ul class="wp-block-list">
<li>Build your portfolio with ETFs — track the S&amp;P 500, tech, energy, and more. Here's <a href="https://robinhood.c3me6x.net/POYEKe">where to invest with no commissions and no account minimums</a>.</li>
<li>Make your savings work harder with a <a href="https://www.pqr3ntrk.com/3P8KRP/37GQ4B/?sub1=y2investing">high-yield cash account with 4.1% APY</a>, with no fees, no minimum balance requirements, and unlimited withdrawals.</li>
</ul>
Investor appetite was also buoyed by a surprise rebound in U.S. consumer confidence and a broad rally in sovereign bonds that pushed the 30-year Treasury yield below 5%. The euro edged to a one-month high near $1.14, underlining renewed demand for European assets as trade tensions eased.
<h2 class="wp-block-heading">Why Fast-Tracking Matters for Markets</h2>
The EU's decision to accelerate negotiations narrows the window for tariff escalation and gives multinationals on both sides of the Atlantic greater clarity on supply-chain planning. Strategists at several banks said the shift could help unlock pent-up capital flows into European equities, which have lagged U.S. benchmarks this year despite attractive valuations and stabilising economic data.
With global manufacturers still digesting China-linked slowdowns, an end to the EU-U.S. tariff standoff would remove a second major source of uncertainty. Semiconductor bellwether Nvidia Corp's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) anticipated earnings report on Wednesday may reinforce the global risk-on tone if guidance proves resilient.
<h2 class="wp-block-heading">Three Routes to European Exposure</h2>
For U.S. investors looking to position ahead of a potential trade agreement, here are a range of vehicles that balance simplicity, liquidity and sector choice.
Broad-based Europe ETFs. Low-cost funds such as the Vanguard FTSE Europe ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGK#NYSE">VGK</a>) or the iShares MSCI Eurozone ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/EZU#BATS">EZU</a>) provide one-ticket exposure to large-cap names across the continent, from French luxury houses to German industrials. Both funds saw above-average volumes on Tuesday.
Sector and thematic funds. Should tariff relief materialize, cyclical areas tied to cross-border demand could benefit most. The SPDR MSCI Europe Industrials ETF and the Global X MSCI SuperDividend EAFE ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFAS#NYSE">EFAS</a>) offer targeted plays on industrial exporters and high-dividend stalwarts, respectively.
Individual ADRs and direct listings. Investors comfortable with single-stock risk may consider American depositary receipts of companies like Siemens AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SIEGY#OTC">SIEGY</a>) or semiconductor equipment maker ASML Holding NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>).&nbsp;
Many discount brokers now route orders directly to Xetra, Euronext or Borsa Italiana, allowing dollar-based accounts to trade in euros and settle in local time.
<h2 class="wp-block-heading">Mind the Currency and Policy Calendar</h2>
A stronger euro can add a second return driver—but also a layer of volatility—when U.S.-based portfolios own unhedged European assets. Currency-hedged ETF share classes are available for investors who prefer to neutralize foreign-exchange swings, albeit at the cost of slightly higher fees.
Traders will also be watching Friday's U.S. core PCE inflation release and a series of speeches from Federal Reserve officials for clues on monetary policy direction. Any hint of slower U.S. growth could amplify relative enthusiasm for Europe, where fiscal spending and structural reforms are expected to underpin domestic demand.
Fast-tracked EU-U.S. negotiations have injected fresh momentum into European markets that were battered by tariff headlines earlier this month. While geopolitical risk remains, the prospect of a negotiated settlement—combined with attractive valuations and a weaker U.S. dollar—makes a diversified allocation to Europe an increasingly compelling complement to a U.S.-centric portfolio.
Browse Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://robinhood.c3me6x.net/POYEKe">Open an IRA with Robinhood and get up to a 3% match on deposits</a> — just like a 401(k), but without the employer. Start investing now, commission-free.</li>
<li>Have $200,000 or more  in investable assets? Get a<a href="https://www.rm2djk4ss.com/BW4BPX/J8P3N/?sub1=y2investing"> free consultation with a financial advisor to learn about retirement and tax-saving strategies</a>. </li>
</ul>
Image: Shutterstock

ETFs

ASML

EFAS

NVDA

SIEGY

EU Trade Talks Accelerate—Invest in Europe's Top Markets Now

IMNN

Imunon shares are trading higher after the company announced it will present IMNN-001 data based on its immune biomarker analysis from its Phase 2 OVATION 2 study at ESMO Gynaecological  Cancers Congress 2025

<a href="https://www.globenewswire.com/Tracker?data=yuQcBQPkFSEdDwWzm5dpE1ByDc7CddcHn2ESD9JX49yjLtvZoi79vi842LU0LMtleB8axmQDAORg-cQuZoaiR2QquuKR9VpKmVa1btNqr50=">Red Cat Holdings, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) ("Red Cat"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, today announced a partnership with <a href="https://www.globenewswire.com/Tracker?data=-ku6RdjUKcp-8UHUkumWZ-VyAxIEigvh2moNk3CjIKJN923mWOu49zpiqlFxdMIKyFkTtimzS-s0n5MegSrsmw==">ESAero</a> to provide critical AS9100 manufacturing capacity for the Black Widow sUAS and its subsystems. The AS9100 standard ensures a manufacturer has a quality management system in place to meet the stringent requirements of the aerospace industry.
Teal Drones is a wholly owned subsidiary of Red Cat Holdings. The company's Black Widow drone is a small unmanned aerial system (sUAS) designed for short-range reconnaissance (SRR) missions. The system, which was down selected for the U.S. Army's SRR Program of Record contract, provides military operators with improved situational awareness, autonomous capabilities, and rugged performance in contested environments.

News

RCAT

Red Cat Holdings Partners With ESAero To Provide Critical AS9100 Manufacturing Capacity For Black Widow sUAS And Its Subsystems

ORIC

Oric Pharmaceuticals shares are trading lower. The company presented data from its Phase 1b trial of ORIC-944 in combination with Androgen.

Treasury yields slipped Tuesday as investors welcomed signs of progress in U.S.–European Union trade talks and relief from a recent bond-market scare in Japan. The move gives income-seekers another—perhaps fleeting—chance to capture the highest government bond coupons in nearly two decades.
The 30-year Treasury yield retreated to about 4.96%, roughly 14 basis points below last week's peak, after President Donald Trump postponed a planned 50% tariff on EU imports until July 9 and Brussels agreed to fast-track negotiations. Shorter maturities followed suit, though the policy-sensitive two-year note still hovered near 4.90% ahead of Friday's core PCE inflation release.
Don't Miss:&nbsp;
<ul class="wp-block-list">
<li>Markets expect rate cuts, but your earnings don't need to suffer:  <a href="https://www.pqr3ntrk.com/3P8KRP/37GQ4B/?sub1=y2investing">lock in a 7.2% yield on bonds until 2028 today.</a></li>
<li>Make your savings work harder with a <a href="https://www.pqr3ntrk.com/3P8KRP/37GQ4B/?sub1=y2investing">high-yield cash account with 4.1% APY</a>, with no fees, no minimum balance requirements, and unlimited withdrawals.</li>
</ul>
A global rally in sovereign debt added momentum. Tokyo hinted it would trim upcoming bond issuance after a sharp sell-off had driven Japanese 30-year yields to record highs. The prospect of steadier supply from the world's third-largest bond market helped drag U.S. yields lower, while the dollar advanced against major peers.
Stocks cheered the reprieve. The Dow Jones Industrial Average jumped about 600 points and the Nasdaq Composite climbed more than 2% as consumer-confidence data posted its largest monthly gain in four years. Yet fixed-income desks cautioned that the window to lock in premium yields could narrow quickly if cooling trade rhetoric and softer inflation data encourage the Federal Reserve to talk more openly about rate cuts.
<h2 class="wp-block-heading">Why Locking In Matters</h2>
Even after Tuesday's move, benchmark yields remain well above the 30-year average. The 10-year note, trading near 4.50%, still offers more than twice its pre-pandemic range. Investment-grade corporate spreads have stayed tight, giving savers a rare opportunity to secure mid-single-digit coupons without venturing deep into junk territory.
Money-market funds and online savings accounts are also paying north of 4%, but those rates reset quickly when the Fed pivots. By contrast, Treasury-bill ladders and certificates of deposit maturing in 2026 or 2027 can lock in today's elevated yields while preserving capital if growth softens.
Institutional investors are taking notice. Bond funds saw the largest weekly inflow in three months ahead of Tuesday's rally, according to EPFR Global data, while Treasury auctions last week drew robust bid-to-cover ratios despite Moody's recent downgrade of U.S. sovereign credit.
<h2 class="wp-block-heading">What Could Drive Yields Even Lower</h2>
<ul class="wp-block-list">
<li>Trade détente: A negotiated EU-U.S. tariff compromise would remove a major threat to global supply chains and growth expectations, lifting demand for safer assets.</li>
<li>Fed rhetoric: Policymakers are widely expected to hold rates steady, but any hint that slower inflation or tighter credit conditions could spark cuts in early 2026 would reinforce the bid for bonds.</li>
<li>Foreign demand: A weaker dollar—already on track for its fifth straight monthly decline—makes Treasurys cheaper for overseas buyers. Japanese pension funds in particular may step up purchases if domestic yields remain capped.</li>
</ul>
<h2 class="wp-block-heading">How Investors Can Act</h2>
Some experts suggest staggering purchases across maturities—four-week bills through five-year notes—to capture current coupons while preserving liquidity. Laddering also mitigates the risk of reinvesting a lump sum at lower rates should yields drop sharply.
For those willing to assume modest credit risk, short-duration investment-grade bond ETFs still yield around 5%. Tax-advantaged municipal bonds have lagged the Treasury rally and now offer attractive taxable-equivalent yields for high-income households.
Cash remains king for flexibility, but the bond-market repricing suggests the easy money may not last. With the term premium trending down alongside easing trade tensions, Tuesday's elevated yields could represent the upper bound of the cycle—one more reason to lock them in before they fade.
Browse Next:&nbsp;
<ul class="wp-block-list">
<li>This Jeff Bezos-backed startup lets you <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=y2investing">become a landlord in just 10 minutes, with minimum investments as low as $100</a>.</li>
<li>Have $200,000 or more  in investable assets? Get a<a href="https://www.rm2djk4ss.com/BW4BPX/J8P3N/?sub1=y2investing"> free consultation with a financial advisor to learn about retirement and tax-saving strategies</a>. </li>
</ul>
Image: Shutterstock

Bonds

Treasury Yields Dip as Trade Tensions Ease—Lock In High Rates Before They Fall

MBAV

MBAVU

M3-Brigade Acquisition V Corp shares are trading higher after the company announced leadership changes for its CEO and president roles. Also, the company bought back 7.1 million class B shares and 8.3 million warrants for approximately $6.47 million.

Organigram Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/OGI#TSX">OGI</a>), Canada&#8217;s leading cannabis company by market share, has announced that CEO Beena Goldenberg will retire at the end of the company's fiscal year, September 30, 2025.
Goldenberg, who joined Organigram as CEO in September 2021, will remain in her role and on the company's board until that time to ensure a smooth transition and continued execution of strategic objectives, including the company's international expansion and entry into the U.S. market.
<h2 class="wp-block-heading">From $80M To $250M: A Transformational Tenure</h2>
During her four-year tenure, Goldenberg led the company's growth from $80 million in net revenue to more than $250 million, making Organigram the market share leader in Canada, according to the company.
Key milestones under her leadership include:
<ul class="wp-block-list">
<li>A doubling of cultivation capacity at the company's Moncton, New Brunswick facility</li>
<li>Acquisitions that positioned Organigram as Canada's #1 player in vapes, hash and pre-rolls</li>
<li>Launch of international exports into Germany, the UK and Australia</li>
<li>The April 2025 acquisition of Collective Project, marking the company's first revenue in the U.S.</li>
</ul>
"This announcement follows the Company's second quarter fiscal year 2025 results, which were issued on May 12, 2025, and highlight the progress that has been made in enhancing Organigram's financial performance," the company said. That included a 74% year-over-year increase in net revenue, along with improvements across other key financial metrics.
<h2 class="wp-block-heading">Goldenberg Reflects On The Cannabis Journey</h2>
"After five incredible years in the cannabis industry, serving as CEO of Supreme Cannabis Company and Organigram Global, I have decided it is time to move on to my next chapter," Goldenberg said in a statement.
"Reflecting on my journey, I am extremely proud of what has been accomplished in this nascent industry. The challenges we faced and the successes we achieved underscore the immense potential that still lies ahead for the cannabis industry."
She added: "Over the next four months I will remain focused on driving Organigram growth and profitability while supporting the smooth onboarding of a new CEO to lead the company forward in its next phase of growth."
<h2 class="wp-block-heading">A Search For The Next Chapter</h2>
Peter Amirault, chairman of the board at Organigram, praised Goldenberg's impact on the company's trajectory.
"On behalf of the Board, I express our gratitude to Beena for her exceptional leadership and commitment to Organigram," he said. "She has created an excellent base for both domestic and international growth&#8230; The Board remains confident in the Company's strategic direction as well as its leadership team and we are committed to appointing a new CEO who will continue to drive our vision forward."
A comprehensive CEO selection process has been initiated, with a focus on finding a candidate equipped to lead Organigram through its next phase of growth and innovation.
Photo: Shutterstock

Cannabis

Management

TSX:OGI

Organigram CEO To Retire After Building Canada's Largest Cannabis Brand: Here's What's Next

Shares of CoreWeave, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) are trading higher Tuesday following the company's announcement of a key <a href="https://www.benzinga.com/pressreleases/25/05/n45616853/coreweave-appoints-new-vice-president-for-government-affairs-carl-holshouser">leadership appointment. </a>
What To Know: The AI infrastructure provider named Carl Holshouser as Vice President of Government Affairs, a move that appears to have boosted investor confidence in the company's regulatory and public sector strategy.
Holshouser brings two decades of experience in public affairs and federal policy, having most recently served as Executive Vice President and Head of Federal Policy and Government Relations at TechNet, a bipartisan network of tech executives. His background includes senior roles at Visa, where he managed global policy on AI, data privacy and fintech, as well as policy leadership in Washington, D.C.
CoreWeave's CEO, Michael Intrator, said Holshouser will lead the company's engagement with public policy and regulatory matters at a time when government decisions are increasingly shaping the AI industry. The company emphasized that Holshouser's role will involve aligning its business goals with emerging AI regulations and strengthening its presence in public sector discussions.
The leadership expansion could reflect CoreWeave's intent to position itself more prominently in AI infrastructure and to navigate the complex regulatory environment surrounding the fast-evolving industry.
CRWV Price Action: Coreweave shares were up 16% at $119.20 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45616116/trumps-tariffs-may-trigger-an-inflation-shock-but-not-a-lasting-one-goldman-sachs-says">Trump&#8217;s Tariffs May Trigger An Inflation Shock &#8211; But Not A Lasting One, Goldman Sachs Says </a></li>
</ul>
Image Via Shutterstock.

Movers

CRWV

CoreWeave Stock Rises On Government Affairs Appointment: What's Going On?

Germany imported a record 37.2 tons of medical cannabis in the first quarter of 2025, marking a 4.6x increase compared to the same period last year, <a href="https://www.bfarm.de/DE/Bundesopiumstelle/_FAQ/Medizinisches-Cannabis/MedCan-Einfuhr-Ausfuhr/faq-liste.html">according</a> to the Federal Institute for Drugs and Medical Devices (BfArM). Per publicly available data, the country is now the largest importer of legal medical cannabis in the world, yet looming regulatory headwinds are already taking shape.
<h2 class="wp-block-heading">German Market Sets A New Benchmark</h2>
The Q1 2025 import surge, which includes dried flower and extracts (converted to flower equivalents), builds on momentum following Germany's April 2024 medical cannabis reform under the Cannabis Act (MedCanG). The previous quarterly record was 32.1 tons in Q4 2024.
"The latest quarterly figures for cannabis imports send a clear message: we are on track for 150 tons of cannabis to be imported into Germany for medical and scientific purposes by 2025. As of today, Germany is likely already the largest medical cannabis market in the world," said Niklas Kouparanis, CEO and co-founder of Bloomwell Group, one of Germany's leading cannabis platforms.
"The main reason for this remarkable progress is low-threshold digital access. This has enabled several hundred thousand patients, who previously obtained medical cannabis illegally (which involved considerable risks), to access legal medical cannabis prescribed by physicians and dispensed in licensed pharmacies," he continued.
Also read: <a href="https://www.benzinga.com/markets/cannabis/25/05/45297889/germanys-cannabis-industry-hits-e500m-2500-pharmacies-now-dispense-211-grow-clubs-approved">Germany&#8217;s Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approved</a>
Based on the latest research from Zuanic &amp; Associates, Germany's actual pharmacy purchases in Q1 2025 are estimated at 22.3 tons. If fewer imports were rejected or re-exported than in previous years, real domestic consumption could be as high as 28 tons.
At an estimated retail price of €8 per gram, this puts Germany's medical cannabis market at an annual run-rate of €714 to €900 million, or roughly $770 million to $970 million.
<h2 class="wp-block-heading">Who&#8217;s Supplying The Boom?</h2>
Canada continues to be the top source, responsible for 43% of all German imports in Q1 2025, followed by Portugal (32%) and Denmark (7%). However, analysts point out that much of Portugal's share consists of Canadian cannabis processed under EU-GMP guidelines before re-export to Germany.
This benefits several Canadian licensed producers, including:
<ul class="wp-block-list">
<li>Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>), which reported $13.9 million in international medical cannabis sales in its latest quarter</li>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>), which shipped C$26.3 million worth of cannabis to Europe in the December quarter, according to estimates from Zuanic &amp; Associates.</li>
<li>Village Farms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>), which reported a 3.8x year-over-year increase in medical cannabis exports, per Zuanic &amp; Associates.</li>
<li>Organigram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>), with approximately 80% growth year-over-year in medical cannabis exports, according to Zuanic &amp; Associates.</li>
<li>Avant Brands (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AVTBF#OTC">AVTBF</a>), which reported C$4.7 million in medical cannabis exports in Q1, per Zuanic &amp; Associates.</li>
</ul>
Curaleaf Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) also plays a major role through its stake in Four20 Pharma, one of Germany's top importers. It has built a global supply chain that includes facilities in Canada, Portugal, the UK, and Poland.
<h2 class="wp-block-heading">Political Risks On The Horizon</h2>
Despite strong fundamentals, the market's long-term stability may be challenged by Germany's new CDU-led coalition. Federal Health Minister Nina Warken has called the growth in medical cannabis use "disturbing" and raised concerns about what she describes as "too easy access."
"With the new government set to review the Cannabis Act rules by the fall, the industry has time to lobby," wrote Pablo Zuanic of Zuanic &amp; Associates, "but restrictions on telehealth are likely, in our view."
Germany's low-barrier digital access is widely credited with accelerating patient uptake, particularly among individuals previously relying on the illicit market. Any changes to telemedicine regulations could have broad implications.
<h2 class="wp-block-heading">There&#8217;s Still Room To Grow</h2>
Even with 37.2 tons of cannabis imported in Q1, Zuanic notes that population penetration remains low—only 0.4% to 0.5% of Germans currently access medical cannabis, compared to 3% to 4% in many U.S. states with mature MMJ programs.
"The German model serves as a model for the entire EU in how to ensure safe, reliable, and digitally-powered access to medical cannabis," Kouparanis said. "There is no turning back."
<h2 class="wp-block-heading">Learn More At Benzinga&#8217;s Cannabis Capital Conference In Chicago</h2>
As Germany&#8217;s market evolves, the implications for global operators and investors will be explored in detail at the <a href="https://www.benzinga.com/cannabis-conference">Benzinga Cannabis Capital Conference</a>, which will take place June 9–10 in Chicago.
Panel: Cracking the German Market: Navigating Cannabis Opportunities Amid Political Change
Speakers:
<ul class="wp-block-list">
<li>Michael Sassano, CEO, Somai Pharmaceuticals</li>
<li>Albert Schwarzmeier, CEO, enua</li>
<li>Chanda Macias, CEO, Women Grow / National Holistic</li>
<li>Constantin von der Groeben, Managing Director, Demecan</li>
<li>Moderator: Jamie Pearson, CEO, New Holland Group</li>
</ul>
Tickets available <a href="https://www.benzinga.com/cannabis-conference">here</a>.
Photo: Shutterstock

Eurozone

AVNT

AVTBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

TLRY

Germany Has Become The World's Largest Cannabis Importer: Here Are The Stocks Benefiting

<a href="https://www.reuters.com/world/asia-pacific/tsmc-still-evaluating-asmls-high-na-intel-eyes-future-use-2025-05-27/">https://www.reuters.com/world/asia-pacific/tsmc-still-evaluating-asmls-high-na-intel-eyes-future-use-2025-05-27/</a>

General

INTC

'TSMC still evaluating ASML's 'High-NA' as Intel eyes future use'- Reuters

Shares of GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) are trading higher Tuesday, continuing a recent uptrend that appears to be fueled by renewed interest from retail investors as well as upward momentum <a href="https://www.benzinga.com/news/25/05/45569674/gamestop-gme-stock-is-rising-thursday-whats-going-on">in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</a>.
What To Know: GameStop shares have gained attention following the company&#8217;s decision earlier this year to adopt Bitcoin as a treasury reserve asset, a move that appears to have helped shares in recent weeks. As Bitcoin surged to new all-time highs last week, retail traders appeared to revisit the name, long considered a meme stock with speculative ties.
GameStop's pivot toward Bitcoin came after months of speculation, beginning with a <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43605313/gamestop-stock-is-surging-monday-whats-going-on">photo</a> of CEO Ryan Cohen alongside Strategy chairman Michael Saylor, the most prominent corporate Bitcoin advocate.
GameStop previously made a push into the crypto space with the launch of wallets that let users manage crypto and non-fungible tokens (NFTs) and also provided access to GameStop&#8217;s NFT marketplace. However, the company closed down the offering in 2023 due to <a href="https://www.benzinga.com/markets/cryptocurrency/23/08/33511904/gamestop-cites-regulatory-uncertainty-drops-ios-chrome-extension-crypto-wallet-support" target="_blank" rel="noreferrer noopener">"regulatory uncertainty."</a>
The company confirmed the rumors during its <a href="https://www.benzinga.com/general/gaming/25/03/44482313/gamestop-q4-earnings-revenue-miss-eps-beat-shares-surge-as-board-approves-bitcoin-as-treasury-reserve-asset">fourth-quarter earnings release</a> in March by updating its investment policy to include Bitcoin holdings. While revenue fell short at $1.28 billion, earnings per share beat expectations and net income more than doubled. The company also ended the quarter with $4.78 billion in cash and equivalents, putting it in a strong position to execute on its new digital asset strategy. GameStop shares are now up about 38% over the past three months.
Meanwhile, AMC Entertainment Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) shares jumped more than 23% on Tuesday after the company <a href="https://www.benzinga.com/25/05/45616728/amc-entertainment-stock-is-rising-tuesday-whats-going-on">reported strong attendance and revenue</a> over the holiday weekend. AMC said it welcomed over seven million guests globally and recorded its highest food and beverage sales for any five-day period this decade. The surge was driven by strong openings for films like Lilo &amp; Stitch and Mission: Impossible — The Final Reckoning, marking what CEO Adam Aron called a turning point for the theater industry.
The coordinated rise in GameStop and AMC shares on Tuesday comes as no surprise to traders familiar with their trading history. Both have been central to meme-stock rallies in recent years and often move in tandem, driven by retail investor momentum and speculative sentiment. With Bitcoin breaking all-time highs and moviegoers returning in record numbers, GameStop and AMC are once again catching the attention of traders looking for outsized moves. 
GameStop is trending on various social platforms as traders highlight technical momentum paired with continued short selling in the name. Gamestop has short interest of 11.93%, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
GME Price Action: GameStop shares were up 4.91% at $34.58 at the time of publication Tuesday, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45616116/trumps-tariffs-may-trigger-an-inflation-shock-but-not-a-lasting-one-goldman-sachs-says">Trump&#8217;s Tariffs May Trigger An Inflation Shock &#8211; But Not A Lasting One, Goldman Sachs Says </a></li>
</ul>
Image via Shutterstock.

$BTC

GameStop Stock Is Rising Again: What's Going On?

The U.S. is no longer a triple-A borrower in the eyes of every major credit assessor.&nbsp;
Moody's Investors Service on May 16 stripped Washington of the last pristine rating still held with the big three agencies, cutting the sovereign score to Aa1 and citing "persistent fiscal deficits and a structurally higher interest-rate environment."
The decision landed in a market already rattled by White House trade brinkmanship and surging Treasury yields. Although U.S. index futures bounced Tuesday after President Donald Trump delayed a threatened 50% tariff on European imports, the downgrade continues to shadow investor sentiment and has revived demand for classic safe-haven assets.
Don't Miss:&nbsp;
<ul class="wp-block-list">
<li><a href="https://robinhood.c3me6x.net/POYEKe">Open an IRA with Robinhood and get up to a 3% match on deposits</a> — just like a 401(k), but without the employer. Start investing now, commission-free.</li>
<li>Have $200,000 or more  in investable assets? Get a<a href="https://www.rm2djk4ss.com/BW4BPX/J8P3N/?sub1=y2investing"> free consultation with a financial advisor to learn about retirement and tax-saving strategies</a>. </li>
</ul>
The federal deficit is projected to top $1.9 trillion this fiscal year, while annual net interest outlays are running near $950 billion—already larger than the Pentagon's budget. With the ten-year Treasury yield hovering around 4.50% and the Federal Reserve keeping policy tight to contain inflation, Wall Street desks expect Washington's funding bill to keep rising.
For households and advisers, the downgrade is a reminder that traditional 60/40 stock-bond mixes are no longer one-decision portfolios. Here are three ways investors can hedge against a drip-feed of fiscal stress without abandoning growth assets altogether.
<h2 class="wp-block-heading">Lean on Gold and Other Real Assets</h2>
Gold tested record highs above $3,400 an ounce earlier this month as traders priced in slower Fed easing and simmering geopolitical risk. While bullion slipped on Tuesday's risk-on tone, strategists still see the metal trading near $3,600 by year-end if real yields move sideways and fiscal worries linger.
Physical bars and low-cost exchange-traded funds like SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) allow investors to add duration-free protection that historically spikes during episodes of sovereign downgrades or debt-ceiling drama. For additional torque, some portfolio managers pair bullion with exposure to energy and industrial metals, given that supply constraints could keep real-asset beta positive even if growth cools.
<h2 class="wp-block-heading">Pivot Toward Defensive-Factor ETFs</h2>
A sovereign-rating scare does not automatically presage a recession (investors on event contract trading website Kalshi peg the chance of recession this year at 40%), but volatility often stays elevated as credit-default swap premia reprice. That backdrop tends to favor sectors with stable cash flows—utilities, consumer staples and health-care majors—over high-beta growth names that dominate the Nasdaq 100.
Low-volatility and quality-dividend ETFs have already begun to outperform the broader S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) since Moody's announcement. Some investors opt for vehicles including Invesco S&amp;P 500 Low Volatility ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPLV#NYSE">SPLV</a>) or ProShares S&amp;P 500 Dividend Aristocrats ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/NOBL#BATS">NOBL</a>) as liquid, rules-based bridges for investors who want equity exposure without the full brunt of index swings.
Because defensive factor funds still trade intraday, they can be rolled back into cyclical sectors once fiscal headlines recede—an important feature for traders wary of sitting in cash while the Dow stages 500-point bursts on tariff relief.
<h2 class="wp-block-heading">Broaden the Income Toolkit</h2>
Higher policy rates mean the short end of the Treasury curve now offers yields unseen in two decades, yet the Moody's downgrade highlights duration risk if Washington's borrowing profile steepens. Some advisers are building laddered Treasury-bill portfolios or buying floating-rate notes that reset coupons as benchmarks adjust.
Others are venturing beyond public markets. Private credit funds that specialize in senior secured loans to middle-market companies can distribute 8% to 10% yields with low correlation to Treasurys, though they come with liquidity locks. Real-estate crowdfunding platforms and precious-metals IRAs have also seen renewed inflows from investors looking to park a slice of wealth outside the traditional stock–bond complex.
While Moody's one-step cut does not jeopardize the Treasury market's role as a global benchmark, it lends to how quickly rising interest costs can erode fiscal credibility.&nbsp;
With Washington likely to continue running large deficits into the next presidential term, investors may benefit from a layered defense; real assets for inflation and currency hedging, defensive equities for lower volatility and alternative-income streams that are less sensitive to sovereign spreads.
Just as importantly, the downgrade is a timely prompt to stress-test portfolios against scenarios where the bond market demands a higher risk premium from the world's largest debtor—an exercise that, until recently, many thought might never be necessary.
Browse Next:&nbsp;
<ul class="wp-block-list">
<li>This Jeff Bezos-backed startup lets you <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=y2investing">become a landlord in just 10 minutes, with minimum investments as low as $100</a>.</li>
<li>Protect your future with precious metals: <a href="https://tracking.hgoldgroup.com/aff_c?offer_id=40&amp;aff_id=1053&amp;aff_sub=y2investing">American Hartfold Gold's IRAs start at $10K, direct buys at $5K</a> — plus free shipping, price match, and easy buyback.</li>
</ul>
Image: Shutterstock

Personal Finance

NOBL

PowerShares S&P 500 Low Volatility Portfolio

SPLV

Moody's Downgrades U.S. Debt—3 Ways To Protect Your Portfolio

In a telling reversal in the universe of <a href="https://www.benzinga.com/etfs">passive investing</a>, frugal investors are seemingly voting with their feet, away from traditional heavyweight SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and toward its cheaper counterpart, the Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>). FactSet data, cited by etf.com, shows that VOO saw $14.9 billion in net inflows during the 30 days ended May 22, while SPY saw the biggest outflows of any exchange-traded fund, $17.3 billion.
Also Read: <a href="https://www.benzinga.com/etfs/currency-etfs/25/05/45624803/forget-stocks-these-currency-etfs-are-where-tactical-traders-can-park-their-cash">Forget Stocks, These Currency ETFs Are Where Tactical Traders Can Park Their Cash</a>
This sharp divergence of fund flows between two virtually identical S&amp;P 500-index ETFs reflects a deeper trend of passive asset consolidation where expense ratios are becoming ever more influential in driving investor behavior. While SPY and VOO posted exactly the same 7.1% returns over the past month, the latter&#8217;s lower expense ratio of 0.03% versus SPY&#8217;s 0.09% has appealed to investors operating in an environment of increasing market volatility and macro uncertainty.
As of May 23, VOO had $659.2 billion in assets under management, outpacing SPY&#8217;s $607.9 billion and solidifying its position as the world&#8217;s largest asset under management ETF.
<h1 class="wp-block-heading">Legacy Fund Meets Cost-Effective Upstart</h1>
While SPY boasts the title of being the original U.S.-listed ETF and long the market leader, its expense structure is rapidly becoming a handicap in the presence of lower-cost alternatives. 
SPY exists as a Unit Investment Trust (UIT), which ties its hands when it comes to reinvesting dividends and from exercising flexibility in portfolio management. On the other hand, VOO, an open-end fund structure, permits reinvesting and generally has more optimal tax management.
Liquidity continues to be a differentiator for SPY, particularly among institutional investors who appreciate its narrower bid-ask spreads and rich trading volume. Yet for long-term owners, both retail and institutional, the cost difference seems to be prevailing. The steady drain of assets out of SPY indicates a heightened preference for long-term cost-effectiveness over short-term trading convenience.
<h1 class="wp-block-heading">IVV Vs VOO: Two Low-Cost Colossi, One Champion</h1>
BlackRock&#8217;s iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>) has also registered huge outflows, with $10.2 billion out over the same timeframe as SPY and VOO, even as it provides an expense ratio of 0.03%, equal to VOO&#8217;s. IVV has $586.6 billion in assets and is also an open-end fund structure, theoretically providing the same cost benefit as VOO. Investor bias appears to have fallen overwhelmingly towards Vanguard.
The difference could be in long-term investor sentiment and brand trust. Vanguard&#8217;s brand of client ownership and dominance among long-term passive investors could be tipping the balance. Additionally, VOO recently reached AUM high could be further fueling the &#8220;herding&#8221; tendency commonly experienced in asset flows, as size tends to attract more flows, solidifying its dominance.
BlackRock&#8217;s core equity exposure product lineup, while industry-leading in other areas such as fixed income and thematic strategies, might be losing ground as investors are moving to concentrate positions in one low-cost provider.
<h1 class="wp-block-heading">VOO Becomes The Passive Benchmark</h1>
While VOO keeps setting the pace in inflows and redefining the pecking order in S&amp;P 500 ETFs, investors&#8217; message is unequivocal: in passive investing, basis points matter. Amidst a world where low-fee, high-efficiency investing reigns supreme, Vanguard&#8217;s leader equity ETF is not merely tracking the market, it&#8217;s leading it.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45621929/confidence-bounces-back-thanks-to-us-china-deal-but-consumers-still-play-it-safe">Confidence Bounces Back Thanks To US-China Deal, But Consumers Still Play It Safe</a></li>
</ul>
Photo: Shutterstock

Broad U.S. Equity ETFs

ETF Showdown: VOO Gains Billions While SPY, IVV Bleed Cash

QCOM

Qualcomm shares are trading higher after the company released a study showing that its modems beat Apple's C1 and announced its considering acquiring Alphawave.

<a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45620850/bitcoin-climbs-5-1-amid-pakistans-support-for-btc-mining-whale-shorts-1b">Pseudonymous crypto trader James Wynn</a>, a prominent whale on the Hyperliquid exchange, experienced an $80 million swing in his Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) long position over the past week.
The Hyperliquid <a href="https://hyperdash.info/trader/0x5078c2fbea2b2ad61bc840bc023e35fce56bedb6">dashboard</a> reveals Wynn's latest position, valued at $558.3 million for an unrealized profit of $2.3 million.
The trader previously <a href="https://x.com/lookonchain/status/1927376573155491861">alternated</a> between long and short positions on Bitcoin, losing more than $14 million as the apex crypto briefly dipped below the $109,000 mark in early Tuesday trading.
"Just now, $BTC dropped below $108,300 — once again targeting James Wynn's position," Lookonchain reported, noting Wynn closed part of his long, incurring a $4.75 million loss in that transaction alone, contributing to the day's total deficit.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45622634/usdc-issuer-circle-eyes-600m-raise-in-nyse-ipo-targets-5-4b-valuation">USDC Issuer Circle Eyes $600M Raise In NYSE IPO, Targets $5.4B Valuation</a>
Wynn's total account value on Hyperliquid stood at $18,405,566.93, with a perpetual futures equity of $18,405,335.36 and a spot balance of $223,157.0148. 
His margin usage was at 75.84%, with $13,955,174.89 committed and $256,110.92 in funding costs. 
The dashboard's position distribution graph illustrates the rapid swing, peaking at a $5 million profit around 10:00 AM before plunging to a $15 million loss by 6:00 PM.
Wynn pushed back against Lookonchain's reporting, <a href="https://x.com/JamesWynnReal/status/1927329341764935927">claiming</a> misrepresentation.
"What you're saying, incorrect information like this is opening you up to a lawsuit, making fake claims like this that are not true," he posted on X, accusing the firm of recent inaccuracies. 
In total, the trader has gone from a peak account profit of $66 million on May 23 to $11 million at the time of writing, losing $55 million in paper gains in four days.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45616666/dogecoin-shiba-inu-and-other-meme-coins-are-entry-points-to-crypto-ecosystem-report">Dogecoin, Shiba Inu And Other Meme Coins Are Entry Points To Crypto Ecosystem: Report</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Bitcoin Whale In Stormy Waters, Down $55 Million From All-Time High In 4 Days

Advanced Micro Devices shares are trading higher. HSBC upgraded the stock from Reduce to Hold.

Walt Disney shares are trading higher after the Lili and Stitch remake led the Box Office and generated $341 million globally so far.

Wall Street charged higher Tuesday, with U.S. equities posting broad-based gains by midday as investors embraced a risk-on mood, spurred by easing Treasury yields and renewed optimism surrounding trade talks between the U.S. and the European Union.
The bond market drove a major sentiment shift. U.S. 30-year Treasury yields sank 10 basis points to 4.93%, falling below the psychologically key 5% threshold for the first time in days. 
The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) rallied 1.5%, eyeing the strongest daily gain since late February 2025. 
This move follows a surprise development in Japan, where the Ministry of Finance announced a reduction in the issuance of longer-dated government bonds. That decision triggered an 18-basis-point drop in Japan's 30-year yield, creating a ripple effect that eased pressure across global fixed-income markets.
The sharp decline in yields helped equities rally across the board. The S&amp;P 500 rose 1.9%, extending May&#8217;s gains to more than 6%. The benchmark is now tracking its strongest monthly performance since November 2023.
Technology and small-cap stocks outpaced broader benchmarks, adding momentum to the rally. Every sector in the S&amp;P 500 traded higher on the day. 
Among the mega-caps, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stood out with a 6.4% gain, reclaiming price levels last seen in mid-February. 
As equity and bond sentiment improved, traditional safe-haven assets lost appeal. Gold prices fell 1%, slipping below $3,300 per ounce. The move reflects investors rotating out of defensive plays amid increasing appetite for risk.
In energy markets, crude oil dropped 1.5% to $60.50 a barrel, while copper prices slid 2.1%, signaling some caution in industrial demand despite the bullish tone in equities.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) traded near $110,000, remaining close to its all-time highs. 
<h1 class="wp-block-heading">Tuesday&#8217;s Performance In Major U.S/ Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day chg. %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,406.38</td>
<td>2.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,085.63</td>
<td>2.2%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,913.36</td>
<td>1.9%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,271.70</td>
<td>1.6%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 1:15 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rallied 1.9% to $590.07.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 1.6% to $422.83.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;soared 2.3% to $520.83.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 2.3% to $207.26.</li>
<li>The&nbsp;Consumer Discretionary&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 2.8%; the&nbsp;Consumer&nbsp;Staples Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) lagged, up 0.5%. </li>
</ul>
<h1 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h1>
<ul class="wp-block-list">
<li>Hologic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>) jumped 12.7%, paring earlier bigger gains, after the company rejected a non-binding takeover bid worth up to $16.7 billion from private equity firms TPG Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) and Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>).</li>
<li>PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) tumbled 15% after reporting weaker-than-expected quarterly earnings. </li>
<li>The S&amp;P 500&#8216;s top performers during Tuesday&#8217;s New York session included Hologic Inc., up 14.93%; Tesla Inc., which gained 6.87%; Deckers Outdoor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>), rising 6.82%; Royal Caribbean Cruises Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>), up 6.66% and Warner Bros. Discovery Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>), climbing 6.61%.</li>
<li>The biggest laggards included Fair Isaac Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>), which sank 9.63%; AutoZone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) down 4.55%; VeriSign Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>) losing 4.28%; Kroger Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) slipping 1.70% and Copart Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) falling 1.68%.</li>
<li>
<path fill-rule="evenodd" clip-rule="evenodd" d="M7 5C7 3.34315 8.34315 2 10 2H19C20.6569 2 22 3.34315 22 5V14C22 15.6569 20.6569 17 19 17H17V19C17 20.6569 15.6569 22 14 22H5C3.34315 22 2 20.6569 2 19V10C2 8.34315 3.34315 7 5 7H7V5ZM9 7H14C15.6569 7 17 8.34315 17 10V15H19C19.5523 15 20 14.5523 20 14V5C20 4.44772 19.5523 4 19 4H10C9.44772 4 9 4.44772 9 5V7ZM5 9C4.44772 9 4 9.44772 4 10V19C4 19.5523 4.44772 20 5 20H14C14.5523 20 15 19.5523 15 19V10C15 9.44772 14.5523 9 14 9H5Z" fill="currentColor"></path>
<path fill-rule="evenodd" clip-rule="evenodd" d="M12.1318 2.50389C12.3321 2.15338 12.7235 1.95768 13.124 2.00775L13.5778 2.06447C16.0449 2.37286 17.636 4.83353 16.9048 7.20993L16.354 8.99999H17.0722C19.7097 8.99999 21.6253 11.5079 20.9313 14.0525L19.5677 19.0525C19.0931 20.7927 17.5124 22 15.7086 22H6C4.34315 22 3 20.6568 3 19V12C3 10.3431 4.34315 8.99999 6 8.99999H8C8.25952 8.99999 8.49914 8.86094 8.6279 8.63561L12.1318 2.50389ZM10 20H15.7086C16.6105 20 17.4008 19.3964 17.6381 18.5262L19.0018 13.5262C19.3488 12.2539 18.391 11 17.0722 11H15C14.6827 11 14.3841 10.8494 14.1956 10.5941C14.0071 10.3388 13.9509 10.0092 14.0442 9.70591L14.9932 6.62175C15.3384 5.49984 14.6484 4.34036 13.5319 4.08468L10.3644 9.62789C10.0522 10.1742 9.56691 10.5859 9 10.8098V19C9 19.5523 9.44772 20 10 20ZM7 11V19C7 19.3506 7.06015 19.6872 7.17071 20H6C5.44772 20 5 19.5523 5 19V12C5 11.4477 5.44772 11 6 11H7Z" fill="currentColor"></path>
<path fill-rule="evenodd" clip-rule="evenodd" d="M11.8727 21.4961C11.6725 21.8466 11.2811 22.0423 10.8805 21.9922L10.4267 21.9355C7.95958 21.6271 6.36855 19.1665 7.09975 16.7901L7.65054 15H6.93226C4.29476 15 2.37923 12.4921 3.0732 9.94753L4.43684 4.94753C4.91145 3.20728 6.49209 2 8.29589 2H18.0045C19.6614 2 21.0045 3.34315 21.0045 5V12C21.0045 13.6569 19.6614 15 18.0045 15H16.0045C15.745 15 15.5054 15.1391 15.3766 15.3644L11.8727 21.4961ZM14.0045 4H8.29589C7.39399 4 6.60367 4.60364 6.36637 5.47376L5.00273 10.4738C4.65574 11.746 5.61351 13 6.93226 13H9.00451C9.32185 13 9.62036 13.1506 9.8089 13.4059C9.99743 13.6612 10.0536 13.9908 9.96028 14.2941L9.01131 17.3782C8.6661 18.5002 9.35608 19.6596 10.4726 19.9153L13.6401 14.3721C13.9523 13.8258 14.4376 13.4141 15.0045 13.1902V5C15.0045 4.44772 14.5568 4 14.0045 4ZM17.0045 13V5C17.0045 4.64937 16.9444 4.31278 16.8338 4H18.0045C18.5568 4 19.0045 4.44772 19.0045 5V12C19.0045 12.5523 18.5568 13 18.0045 13H17.0045Z" fill="currentColor"></path>
<path fill-rule="evenodd" clip-rule="evenodd" d="M11 4.9099C11 4.47485 10.4828 4.24734 10.1621 4.54132L6.67572 7.7372C6.49129 7.90626 6.25019 8.00005 6 8.00005H4C3.44772 8.00005 3 8.44776 3 9.00005V15C3 15.5523 3.44772 16 4 16H6C6.25019 16 6.49129 16.0938 6.67572 16.2629L10.1621 19.4588C10.4828 19.7527 11 19.5252 11 19.0902V4.9099ZM8.81069 3.06701C10.4142 1.59714 13 2.73463 13 4.9099V19.0902C13 21.2655 10.4142 22.403 8.81069 20.9331L5.61102 18H4C2.34315 18 1 16.6569 1 15V9.00005C1 7.34319 2.34315 6.00005 4 6.00005H5.61102L8.81069 3.06701ZM20.3166 6.35665C20.8019 6.09313 21.409 6.27296 21.6725 6.75833C22.5191 8.3176 22.9996 10.1042 22.9996 12.0001C22.9996 13.8507 22.5418 15.5974 21.7323 17.1302C21.4744 17.6185 20.8695 17.8054 20.3811 17.5475C19.8927 17.2896 19.7059 16.6846 19.9638 16.1962C20.6249 14.9444 20.9996 13.5175 20.9996 12.0001C20.9996 10.4458 20.6064 8.98627 19.9149 7.71262C19.6514 7.22726 19.8312 6.62017 20.3166 6.35665ZM15.7994 7.90049C16.241 7.5688 16.8679 7.65789 17.1995 8.09947C18.0156 9.18593 18.4996 10.5379 18.4996 12.0001C18.4996 13.3127 18.1094 14.5372 17.4385 15.5604C17.1357 16.0222 16.5158 16.1511 16.0539 15.8483C15.5921 15.5455 15.4632 14.9255 15.766 14.4637C16.2298 13.7564 16.4996 12.9113 16.4996 12.0001C16.4996 10.9859 16.1653 10.0526 15.6004 9.30063C15.2687 8.85905 15.3578 8.23218 15.7994 7.90049Z" fill="currentColor"></path>
<path d="M2.5 5.5C4.3 5.2 5.2 4 5.5 2.5C5.8 4 6.7 5.2 8.5 5.5C6.7 5.8 5.8 7 5.5 8.5C5.2 7 4.3 5.8 2.5 5.5Z" fill="currentColor" stroke="currentColor" stroke-linecap="round" stroke-linejoin="round"></path>
<path d="M5.66282 16.5231L5.18413 19.3952C5.12203 19.7678 5.09098 19.9541 5.14876 20.0888C5.19933 20.2067 5.29328 20.3007 5.41118 20.3512C5.54589 20.409 5.73218 20.378 6.10476 20.3159L8.97693 19.8372C9.72813 19.712 10.1037 19.6494 10.4542 19.521C10.7652 19.407 11.0608 19.2549 11.3343 19.068C11.6425 18.8575 11.9118 18.5882 12.4503 18.0497L20 10.5C21.3807 9.11929 21.3807 6.88071 20 5.5C18.6193 4.11929 16.3807 4.11929 15 5.5L7.45026 13.0497C6.91175 13.5882 6.6425 13.8575 6.43197 14.1657C6.24513 14.4392 6.09299 14.7348 5.97903 15.0458C5.85062 15.3963 5.78802 15.7719 5.66282 16.5231Z" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"></path>
<path d="M14.5 7L18.5 11" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"></path>
<div class="text-center"></div>
<path d="M7.5 13.25C7.98703 13.25 8.45082 13.1505 8.87217 12.9708C8.46129 14.0478 7.62459 15.5792 6.35846 15.76C5.81173 15.8382 5.43183 16.3447 5.50993 16.8914C5.58804 17.4382 6.09457 17.8181 6.6413 17.7399C9.19413 17.3753 10.7256 14.4711 11.169 12.1909C11.4118 10.942 11.3856 9.58095 10.8491 8.44726C10.2424 7.16517 8.92256 6.24402 7.48508 6.25001C5.55895 6.25805 4 7.82196 4 9.74998C4 11.683 5.567 13.25 7.5 13.25Z" fill="currentColor"></path>
<path d="M16.18 13.25C16.667 13.25 17.1308 13.1505 17.5522 12.9708C17.1413 14.0478 16.3046 15.5792 15.0385 15.76C14.4917 15.8382 14.1118 16.3447 14.1899 16.8914C14.268 17.4382 14.7746 17.8181 15.3213 17.7399C17.8741 17.3753 19.4056 14.4711 19.849 12.1909C20.0918 10.942 20.0656 9.58095 19.5291 8.44726C18.9224 7.16517 17.6026 6.24402 16.1651 6.25001C14.2389 6.25805 12.68 7.82196 12.68 9.74998C12.68 11.683 14.247 13.25 16.18 13.25Z" fill="currentColor"></path>
<div aria-hidden="true" data-edge="true" class="pointer-events-none h-px w-px"></div>
Stocks slated to report earnings after the close include OKTA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) and Heico Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>). Read Now: • <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45616116/trumps-tariffs-may-trigger-an-inflation-shock-but-not-a-lasting-one-goldman-sachs-says">Trump&#8217;s Tariffs May Trigger An Inflation Shock &#8211; But Not A Lasting One, Goldman Sachs Says</a> Photo: Shutterstock</li>
</ul>

Equities

Government

Large Cap

Macro Economic Events

Mid Cap

Regulations

Treasuries

Global

Econ #s

Economics

Tech

CPRT

DECK

SPDR Dow Jones Industrial Average ETF Trust

FICO

HOLX

OKTA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

VRSN

Select Sector SPDR-Consumer Discretionary

Wall Street Rockets As Bond Yields Drop, Tesla Hits 3-Month Highs: What's Driving Markets Tuesday?

Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Teladoc Health and provided 12-month price targets. The average target is $9.43, accompanied by a high estimate of $13.00 and a low estimate of $7.00. This current average has decreased by 16.03% from the previous average price target of $11.23. 
<img src="https://www.benzinga.com/files/images/story/2025/1748368868_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of Teladoc Health by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jailendra Singh</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$9.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Stan Berenshteyn</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$8.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Richard Close</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>David Roman</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$10.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>David Grossman</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$8.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$7.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Daniel Grosslight</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$8.75</td>
<td>$11.00</td>
</tr>
<tr>
<td>Glen Santangelo</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$8.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Allen Lutz</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$9.50</td>
</tr>
<tr>
<td>David Roman</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$13.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$12.00</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Teladoc Health. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Teladoc Health compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Teladoc Health's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Teladoc Health's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TDOC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Teladoc Health analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Teladoc Health Better</h2>
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
<h3>Teladoc Health's Economic Impact: An Analysis</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Decline in Revenue: Over the 3M period, Teladoc Health faced challenges, resulting in a decline of approximately -2.59% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Teladoc Health's net margin is impressive, surpassing industry averages. With a net margin of -14.78%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Teladoc Health's ROE excels beyond industry benchmarks, reaching -6.37%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Teladoc Health's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -2.67%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 1.11, Teladoc Health adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Rain Enhancement

Notizie

Ultime notizie per Rain Enhancement (NASDAQ:RAIN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO